BC
CYNA

Broadfin Capital’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Broadfin Capital’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-583,121
Closed -$8.92M – 93
2015
Q4 		$8.92M Sell
583,121
-2,996
-0.5% -$45.5K 0.55% 51
2015
Q3 		$9.05M Sell
586,117
-292,000
-33% -$4.74M 0.5% 52
2015
Q2 		$13.9M Buy
+878,117
New +$14.4M 0.75% 37

Other funds holding CYNA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Broadfin Capital's CYNA Position: Q1 2016 in Review

Broadfin Capital sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q1 2016, closing a stake of 583,121 shares — an estimated $8.92M sold.

Broadfin Capital first reported a position in CYNA in Q2 2015 and held it in 3 quarters. The position peaked at $13.9M in Q2 2015. 31 funds tracked by Wall St. Rank hold CYNA as of Q1 2016.

  • Broadfin Capital reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q1 2016 after selling out during the quarter.
  • Broadfin Capital sold 583,121 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q1 2016, an estimated $8.92M.
  • Broadfin Capital first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q2 2015 and held it in 3 quarters.
  • Broadfin Capital's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $13.9M in Q2 2015.
  • 31 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q1 2016.

Based on Broadfin Capital's 13F filing for Q1 2016, filed 16 May 2016.